Human umbilical cord mesenchymal stem cell-derived exosome-mediated transfer of microRNA-133b boosts trophoblast cell proliferation, migration and invasion in preeclampsia by restricting SGK1.


Journal

Cell cycle (Georgetown, Tex.)
ISSN: 1551-4005
Titre abrégé: Cell Cycle
Pays: United States
ID NLM: 101137841

Informations de publication

Date de publication:
08 2020
Historique:
pubmed: 1 7 2020
medline: 3 9 2021
entrez: 30 6 2020
Statut: ppublish

Résumé

Exosomes have been documented to function in human diseases, yet their transfer of microRNA (miRNA) in preeclampsia (PE) has seldom been reported. This study intends to discuss the role of miR-133b derived from exosomes in human umbilical cord mesenchymal stem cells (hUC-MSCs) in trophoblast cell development in PE. Placentas from PE patients and normal pregnant women were collected. The hUC-MSCs and their exosomes were obtained and identified. Trophoblast cell HPT-8 and HTR8-S/Vneo were obtained and co-cultured with hUC-MSCs-derived exosomes that had been transfected with different miR-133b plasmids. MiR-133b and glucocorticoid-regulated kinase 1 (SGK1) expression in placental tissues and HPT-8 and HTR8-S/Vneo cells was determined. HTR8-S/Vneo and HPT-8 cell proliferation, cell cycle distribution, apoptosis rate, migration and invasion were detected. MiR-133b was down-regulated and SGK1 was up-regulated in placental tissues of PE patients. MiR-133b expression was inversely related to SGK1 expression in HTR8-S/Vneo and HPT-8 cells co-cultured with hUC-MSC-derived exosomes. Exosomes promoted HTR8-S/Vneo and HPT-8 cell proliferation, migration and invasion abilities, cell cycle entry and inhibited apoptosis. Elevated exosome-derived miR-133b from hUC-MSCs boosted HTR8-S/Vneo and HPT-8 cell proliferation, cell cycle progression, migration and invasion and limited cell apoptosis. MiR-133b targeted SGK1. Collectively, we demonstrate that miR-133b is down-regulated and SGK1 is up-regulated in PE, and miR-133b derived from exosomes in hUM-MSCs facilitates trophoblast cell proliferation, migration and invasion in PE via constraining SGK1.

Identifiants

pubmed: 32597300
doi: 10.1080/15384101.2020.1769394
pmc: PMC7469539
doi:

Substances chimiques

Immediate-Early Proteins 0
MIRN133 microRNA, human 0
MicroRNAs 0
Protein Serine-Threonine Kinases EC 2.7.11.1
serum-glucocorticoid regulated kinase EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1869-1883

Références

Front Physiol. 2015 Jan 13;5:516
pubmed: 25628568
Radiat Oncol. 2016 Jun 01;11:75
pubmed: 27251632
Anesthesiol Clin. 2017 Mar;35(1):95-106
pubmed: 28131123
AACN Adv Crit Care. 2018 Fall;29(3):316-326
pubmed: 30185498
Eur Rev Med Pharmacol Sci. 2017 Dec;21(24):5602-5609
pubmed: 29271992
Int J Nanomedicine. 2017 Oct 31;12:8009-8023
pubmed: 29184401
Oncotarget. 2017 Jul 12;8(38):63935-63948
pubmed: 28969042
J Clin Endocrinol Metab. 2016 Apr;101(4):1478-89
pubmed: 26840046
Genomics Proteomics Bioinformatics. 2015 Feb;13(1):17-24
pubmed: 25724326
Oncol Res. 2017 Aug 7;25(7):1109-1116
pubmed: 27938481
Cell Death Dis. 2018 Jul 3;9(7):752
pubmed: 29970901
Front Neurosci. 2018 Nov 22;12:845
pubmed: 30524227
Placenta. 2017 Apr;52:33-40
pubmed: 28454695
Exp Ther Med. 2016 Apr;11(4):1469-1474
pubmed: 27073467
Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):52-60
pubmed: 30657546
J Mol Endocrinol. 2016 May;56(4):301-9
pubmed: 27287220
Br J Cancer. 2017 Oct 10;117(8):1139-1153
pubmed: 29017179
Exp Mol Med. 2017 Nov 24;49(11):e399
pubmed: 29170478
Oncol Rep. 2017 Nov;38(5):3220-3226
pubmed: 28901466
Sci Rep. 2017 May 31;7(1):2552
pubmed: 28566720
Stem Cells. 2012 Jul;30(7):1556-64
pubmed: 22605481
Microrna. 2019;8(1):28-35
pubmed: 30101723
Cell Physiol Biochem. 2016;39(5):1863-1876
pubmed: 27771704
Curr Pharm Des. 2017;23(40):6182-6193
pubmed: 28412904
Lancet. 2010 Aug 21;376(9741):631-44
pubmed: 20598363
Viruses. 2015 Sep 17;7(9):5066-83
pubmed: 26393640
Cell Physiol Biochem. 2017;43(4):1663-1672
pubmed: 29045940
Curr Drug Targets. 2017;18(10):1165-1170
pubmed: 28382860
Cancer Sci. 2016 Dec;107(12):1767-1775
pubmed: 27696637

Auteurs

Dan Wang (D)

Department of Obstetric and Gynecology, Shengjing Hospital of China Medical University , Shengyang, Liaoning, China.

Quan Na (Q)

Department of Obstetric and Gynecology, Shengjing Hospital of China Medical University , Shengyang, Liaoning, China.

Gui Yu Song (GY)

Department of Obstetric and Gynecology, Shengjing Hospital of China Medical University , Shengyang, Liaoning, China.

Leilei Wang (L)

Department of Obstetric and Gynecology, Shengjing Hospital of China Medical University , Shengyang, Liaoning, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH